$ZETA
Zeta Global Holdings Corp.

2023 Q2 Form 10-Q Financial Statement

#000095017023037606 Filed on August 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2
Revenue $171.8M
YoY Change 25.14%
Cost Of Revenue $62.04M
YoY Change 23.5%
Gross Profit $109.8M
YoY Change 26.09%
Gross Profit Margin 63.89%
Selling, General & Admin $123.2M
YoY Change -7.22%
% of Gross Profit 112.23%
Research & Development $17.34M
YoY Change -3.85%
% of Gross Profit 15.8%
Depreciation & Amortization $12.60M
YoY Change -5.4%
% of Gross Profit 11.47%
Operating Expenses $153.2M
YoY Change 1.53%
Operating Profit -$43.37M
YoY Change -43.74%
Interest Expense -$2.797M
YoY Change -267.89%
% of Operating Profit
Other Income/Expense, Net -$2.838M
YoY Change -66.91%
Pretax Income -$51.85M
YoY Change -39.47%
Income Tax $309.0K
% Of Pretax Income
Net Earnings -$52.16M
YoY Change -39.36%
Net Earnings / Revenue -30.36%
Basic Earnings Per Share -$0.34
Diluted Earnings Per Share -$0.34
COMMON SHARES
Basic Shares Outstanding 154.6M
Diluted Shares Outstanding 154.6M

Balance Sheet

Concept 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $117.1M
YoY Change 5.68%
Cash & Equivalents $117.1M
Short-Term Investments
Other Short-Term Assets $7.455M
YoY Change 291.13%
Inventory
Prepaid Expenses $5.393M
Receivables $122.0M
Other Receivables $0.00
Total Short-Term Assets $246.5M
YoY Change 18.13%
LONG-TERM ASSETS
Property, Plant & Equipment $13.13M
YoY Change 137.11%
Goodwill $140.9M
YoY Change 5.92%
Intangibles $52.03M
YoY Change 8.83%
Long-Term Investments
YoY Change
Other Assets $4.117M
YoY Change 66.55%
Total Long-Term Assets $244.7M
YoY Change 7.73%
TOTAL ASSETS
Total Short-Term Assets $246.5M
Total Long-Term Assets $244.7M
Total Assets $491.2M
YoY Change 12.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $55.93M
YoY Change 46.9%
Accrued Expenses $64.46M
YoY Change 21.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $147.3M
YoY Change 18.26%
LONG-TERM LIABILITIES
Long-Term Debt $183.9M
YoY Change 0.09%
Other Long-Term Liabilities $22.63M
YoY Change 884.6%
Total Long-Term Liabilities $206.6M
YoY Change 1.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $147.3M
Total Long-Term Liabilities $206.6M
Total Liabilities $353.9M
YoY Change 7.58%
SHAREHOLDERS EQUITY
Retained Earnings -$880.2M
YoY Change 35.44%
Common Stock $1.019B
YoY Change 34.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $137.3M
YoY Change
Total Liabilities & Shareholders Equity $491.2M
YoY Change 12.71%

Cashflow Statement

Concept 2023 Q2
OPERATING ACTIVITIES
Net Income -$52.16M
YoY Change -39.36%
Depreciation, Depletion And Amortization $12.60M
YoY Change -5.4%
Cash From Operating Activities $20.63M
YoY Change 40.65%
INVESTING ACTIVITIES
Capital Expenditures $10.19M
YoY Change -214.59%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$10.19M
YoY Change 14.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $5.625M
YoY Change
Cash From Financing Activities -1.304M
YoY Change -276.22%
NET CHANGE
Cash From Operating Activities 20.63M
Cash From Investing Activities -10.19M
Cash From Financing Activities -1.304M
Net Change In Cash 9.139M
YoY Change 40.21%
FREE CASH FLOW
Cash From Operating Activities $20.63M
Capital Expenditures $10.19M
Free Cash Flow $10.44M
YoY Change -55.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001851003
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q2 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilities
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40464
dei Entity Registrant Name
EntityRegistrantName
ZETA GLOBAL HOLDINGS CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
80-0814458
dei Entity Address Address Line1
EntityAddressAddressLine1
3 Park Ave, 33rd Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10016
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
967-5055
dei Security12b Title
Security12bTitle
Class A common stock
dei Trading Symbol
TradingSymbol
ZETA
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
117066000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121110000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3030000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1882000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
122023000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
106322000
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5393000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7150000
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2062000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1866000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
246544000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
236448000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6673000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5981000
CY2023Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
34482000
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
36713000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6458000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7388000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
52029000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
44358000
CY2023Q2 us-gaap Goodwill
Goodwill
140903000
CY2022Q4 us-gaap Goodwill
Goodwill
133069000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
771000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
745000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3346000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1800000
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
244662000
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
230054000
CY2023Q2 us-gaap Assets
Assets
491206000
CY2022Q4 us-gaap Assets
Assets
466502000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
55925000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
33668000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
64463000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
72364000
CY2023Q2 zeta Acquisition Related Liabilities Current
AcquisitionRelatedLiabilitiesCurrent
19165000
CY2022Q4 zeta Acquisition Related Liabilities Current
AcquisitionRelatedLiabilitiesCurrent
14743000
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3381000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2228000
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4356000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5707000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
147290000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
128710000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
183942000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
183953000
CY2023Q2 zeta Acquisition Related Liabilities Non Current
AcquisitionRelatedLiabilitiesNonCurrent
15583000
CY2022Q4 zeta Acquisition Related Liabilities Non Current
AcquisitionRelatedLiabilitiesNonCurrent
17932000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7043000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7877000
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
206568000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
209762000
CY2023Q2 us-gaap Liabilities
Liabilities
353858000
CY2022Q4 us-gaap Liabilities
Liabilities
338472000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1019144000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
900924000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-880170000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-771056000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1840000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2045000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
137348000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
128030000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
491206000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
466502000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
171817000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
137301000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
329419000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
263569000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
62037000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
50233000
us-gaap Cost Of Revenue
CostOfRevenue
116387000
us-gaap Cost Of Revenue
CostOfRevenue
91958000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50715000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
55665000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
103316000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
109014000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
72496000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
77139000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
145045000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
146057000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17343000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18038000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35862000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35269000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12596000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
13315000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
24421000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
26081000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
203000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
344000
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
2845000
us-gaap Restructuring Charges
RestructuringCharges
2845000
CY2023Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
218032000
CY2022Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
214390000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
428079000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
408723000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-46215000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-77089000
us-gaap Operating Income Loss
OperatingIncomeLoss
-98660000
us-gaap Operating Income Loss
OperatingIncomeLoss
-145154000
CY2023Q2 us-gaap Interest Expense
InterestExpense
2797000
CY2022Q2 us-gaap Interest Expense
InterestExpense
1666000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
134835401
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154597506
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
135903592
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152334247
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
134835401
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
57612000
us-gaap Interest Expense
InterestExpense
5245000
us-gaap Interest Expense
InterestExpense
2964000
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2838000
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-5696000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-4702000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-10969000
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1215000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1215000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5635000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8577000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9947000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15148000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-51850000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-85666000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-108607000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-160302000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
309000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
343000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
507000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2256000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-52159000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-86009000
us-gaap Net Income Loss
NetIncomeLoss
-109114000
us-gaap Net Income Loss
NetIncomeLoss
-158046000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
58000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-403000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
205000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-647000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-52101000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-86412000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-108909000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-158693000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-52159000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-86009000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-109114000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-158046000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.17
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.17
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154597506
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
135903592
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152334247
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
480000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
82335000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
122074000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
156071000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
128030000
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
6551000
CY2023Q1 zeta Options Exercised During Period Value
OptionsExercisedDuringPeriodValue
41000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
65214000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
147000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-56955000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
129926000
CY2023Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
843000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1567000
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1419000
CY2023Q2 zeta Options Exercised During Period Value
OptionsExercisedDuringPeriodValue
41000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
58491000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
58000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-52159000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
137348000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
90488000
CY2022Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
11083000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
74990000
CY2022Q1 zeta Options Exercised During Period Value
OptionsExercisedDuringPeriodValue
65000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-244000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-72037000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
104345000
CY2022Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
3853000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
83734000
CY2022Q2 zeta Options Exercised During Period Value
OptionsExercisedDuringPeriodValue
65000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-403000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1320000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-86009000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
106905000
us-gaap Profit Loss
ProfitLoss
-109114000
us-gaap Profit Loss
ProfitLoss
-158046000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
24421000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
26081000
us-gaap Share Based Compensation
ShareBasedCompensation
122074000
us-gaap Share Based Compensation
ShareBasedCompensation
156071000
zeta Provision For Deferred Income Taxes
ProvisionForDeferredIncomeTaxes
-32000
zeta Provision For Deferred Income Taxes
ProvisionForDeferredIncomeTaxes
-3090000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1215000
zeta Change In The Fair Value Of Acquisition Related Liabilities
ChangeInTheFairValueOfAcquisitionRelatedLiabilities
4265000
zeta Change In The Fair Value Of Acquisition Related Liabilities
ChangeInTheFairValueOfAcquisitionRelatedLiabilities
10795000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-966000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-570000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15184000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4740000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
5404000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
18334000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1890000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-524000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
196000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-271000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
550000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
703000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
954000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1016000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
20088000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
18703000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-8945000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-10591000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
96000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-194000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40733000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
35850000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8950000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11511000
us-gaap Payments For Software
PaymentsForSoftware
8906000
us-gaap Payments For Software
PaymentsForSoftware
8586000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
18246000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
9157000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36102000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29254000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
2488000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
1292000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
11250000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
5625000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1567000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1320000
zeta Proceeds From Exercise Of Options
ProceedsFromExerciseOfOptions
83000
zeta Proceeds From Exercise Of Options
ProceedsFromExerciseOfOptions
130000
zeta Payments For Repurchase Of Shares
PaymentsForRepurchaseOfShares
7938000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
11250000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
5625000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8776000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
158000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
101000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
166000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4044000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6920000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121110000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103859000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117066000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110779000
us-gaap Interest Paid Net
InterestPaidNet
4983000
us-gaap Interest Paid Net
InterestPaidNet
2486000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
752000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
127925000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
83567000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
44358000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1631000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2653000
us-gaap Stock Issued1
StockIssued1
843000
us-gaap Stock Issued1
StockIssued1
14936000
us-gaap Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset
ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset
513000
us-gaap Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset
ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset
632000
us-gaap Nature Of Operations
NatureOfOperations
<p style="margin-left:1.133%;text-indent:-10.097%;padding-left:9.067%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Organization and Background</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:1.133%;text-indent:-10.097%;padding-left:9.067%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(a)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Nature of Business</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:10.2%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Zeta Global Holdings Corp., a Delaware Corporation ("Zeta" or “Zeta Global Holdings”) and Zeta Global Corp., a Delaware Corporation and the operating company (“Zeta Global” individually, or collectively with Zeta Global Holdings Corp. and its consolidated entities, as context dictates, the “Company”), is a marketing technology company that uses proprietary data, artificial intelligence and software to create a technology platform that enables marketers to acquire, retain and grow customer relationships. The Company’s technology platform powers data-driven marketing programs for enterprises across a wide range of industries and utilizes all digital distribution channels including email, search, social, mobile, display and connected TV. Zeta Global was incorporated and began operations in October 2007.</span></p>
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
4881000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2325000
CY2023Q2 zeta Contract With Customer Liability Amount Billed And Collected In Advance
ContractWithCustomerLiabilityAmountBilledAndCollectedInAdvance
4249000
CY2022Q2 zeta Contract With Customer Liability Amount Billed And Collected In Advance
ContractWithCustomerLiabilityAmountBilledAndCollectedInAdvance
11507000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3096000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12509000
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3381000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2228000
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
60400000
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
74900000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:1.133%;text-indent:-10.097%;padding-left:9.067%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(e)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:10.2%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No customer accounted for more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Company’s total revenues during the six months ended June 30, 2023 and 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:10.2%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments that potentially subject the Company to concentration risk consist primarily of accounts receivable from customers. As of June 30, 2023 and December 31, 2022, respectively, there was no customer that represented more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of accounts receivables balance as of each of those dates. The Company continuously monitors whether there is an expected credit loss arising from customers and accordingly make provisions as warranted. As of the six months ended June 30, 2023, no provision was warranted or recorded.</span></p>
zeta Concentration Risk Threshold Percentage
ConcentrationRiskThresholdPercentage
0.10
zeta Concentration Risk Threshold Percentage
ConcentrationRiskThresholdPercentage
0.10
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
146044000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
94015000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
52029000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5625000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10449000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6425000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12237000
us-gaap Finite Lived Intangible Asset Weighted Average Period Before Next Renewal Or Extension
FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
P3Y25D
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
11510000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
18557000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
12557000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5386000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2542000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1477000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
52029000
CY2022Q4 us-gaap Goodwill
Goodwill
133069000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
10000
CY2023Q2 us-gaap Goodwill
Goodwill
140903000
CY2022Q4 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
32675000
CY2022Q4 us-gaap Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Costs
BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts
1139000
zeta Business Combination Payments To Acquire Businesses Gross
BusinessCombinationPaymentsToAcquireBusinessesGross
3331000
zeta Business Combination Change In Fair Value Ofearnout
BusinessCombinationChangeInFairValueOfearnout
4265000
CY2023Q2 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
34748000
CY2023Q2 us-gaap Deferred Finance Costs Noncurrent Gross
DeferredFinanceCostsNoncurrentGross
1058000
CY2022Q4 us-gaap Deferred Finance Costs Noncurrent Gross
DeferredFinanceCostsNoncurrentGross
1047000
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
183942000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
183953000
CY2023Q2 zeta Total Leverage Ratio
TotalLeverageRatio
2.75
CY2023Q2 zeta Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
1.25
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
11250000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
16875000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
156875000
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
185000000
CY2023Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5625000
CY2023Q2 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
13318000
CY2023Q2 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
31742000
CY2023Q2 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
8584000
CY2023Q2 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
2105000
CY2023Q2 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
620000
CY2023Q2 us-gaap Purchase Obligation
PurchaseObligation
56369000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
57612000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
82335000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
122074000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
156071000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
60107275
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
10.72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
7306903
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.78
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
9053631
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
10.21
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
692435
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
9.46
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
57668112
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
10.7
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
887662
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.53
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y2M8D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5280
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
575250
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.82
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
315430
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.63
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
30990
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
10.83
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1116492
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.9
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M1D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
590
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1714555
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.63
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
25000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
53895
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.95
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2752152
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.39
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M24D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
330
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
673108
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.8
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M13D
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6458000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7388000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1915000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2137000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7043000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7877000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1286000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2128000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1863000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1676000
CY2023Q2 zeta Lessee Operating Lease Liability Payments Due Year Four And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter
3483000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10436000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1478000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
8958000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
7970000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
309000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
507000
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.006
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-51850000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.005
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-108607000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
343000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2256000
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.004
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-85666000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0141
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-160302000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-52159000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-86009000
us-gaap Profit Loss
ProfitLoss
-109114000
us-gaap Profit Loss
ProfitLoss
-158046000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154597506
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154597506
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
135903592
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
135903592
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152334247
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152334247
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
134835401
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
134835401
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.17
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.17

Files In Submission

Name View Source Status
0000950170-23-037606-index-headers.html Edgar Link pending
0000950170-23-037606-index.html Edgar Link pending
0000950170-23-037606.txt Edgar Link pending
0000950170-23-037606-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img140588983_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zeta-20230630.htm Edgar Link pending
zeta-20230630.xsd Edgar Link pending
zeta-ex31_1.htm Edgar Link pending
zeta-ex31_2.htm Edgar Link pending
zeta-ex32_1.htm Edgar Link pending
zeta-ex32_2.htm Edgar Link pending
zeta-20230630_lab.xml Edgar Link unprocessable
zeta-20230630_pre.xml Edgar Link unprocessable
zeta-20230630_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
zeta-20230630_cal.xml Edgar Link unprocessable
zeta-20230630_def.xml Edgar Link unprocessable